Back to VNDA
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
3
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMAPending
Iloperidone Vanda Pharmaceuticals
Iloperidone is indicated for: treatment of schizophrenia in adults acute treatment of manic or mixed episodes associated with bipolar I disorder in adults
View on EMADrug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts